Status:
COMPLETED
Autofluorescence for the Screening of Precancerous and Malignant Lesions
Lead Sponsor:
University Hospital, Bordeaux
Conditions:
Precancerous Lesions of the Oral Mucosa
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Diagnosis of oral squamous cell carcinoma is always too late. Due to this delay for diagnosis, prognosis is very bad. It has been demonstrate that systematic oral examination decrease mortality in tob...
Detailed Description
The study of Sankaranarayanan and al. (Lancet on 2005, 4, 1927-1933) demonstrated the influence on the decline of mortality of a realized systematic screening, by a simple visual inspection of the ora...
Eligibility Criteria
Inclusion
- patients hospitalized for alcoholic weaning
- consumption activates of tobacco or stop for less than one year
- consent form signed
Exclusion
- patient presenting a disorder of the haemostasis (plaques \< 50G / L; INR \> 3, haemophilia, moderate or severe Willebrand disease),
- absorption of acid acetylsalicylic in seven days before inclusion,
- the patient with oral cavity precancerous pathology, dysplasia or known cancer patient
Key Trial Info
Start Date :
July 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2012
Estimated Enrollment :
180 Patients enrolled
Trial Details
Trial ID
NCT01167790
Start Date
July 1 2010
End Date
March 1 2012
Last Update
June 14 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hopital Saint André
Bordeaux, France, 33000